The efficacy of transient TSLP induction in delivering lasting tumor-specific immunity in the skin emphasizes the benefit of using topical TSLP inducers (e.g., calcipotriol) as safe and accessible modalities for skin cancer immunoprevention. This evidence concerns the gene TSLP and neoplasm.